Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy

Introduction Hypertrophic cardiomyopathy (HCM) is a cause of sudden arrhythmic death, but the understanding of its pro-arrhythmic mechanisms and an effective pharmacological treatment are lacking. HCM electrophysiological remodelling includes both increased inward and reduced outward currents, but their role in promoting repolarisation abnormalities remains unknown. The goal of this study is to identify key ionic mechanisms driving repolarisation abnormalities in human HCM, and to evaluate anti-arrhythmic effects of single and multichannel inward current blocks. Methods Experimental ionic current, action potential (AP) and Ca2 +-transient (CaT) recordings were used to construct populations of human non-diseased and HCM AP models (n = 9118), accounting for inter-subject variability. Simulations were conducted for several degrees of selective and combined inward current block. Results Simulated HCM cardiomyocytes exhibited prolonged AP and CaT, diastolic Ca2 + overload and decreased CaT amplitude, in agreement with experiments. Repolarisation abnormalities in HCM models were consistently driven by L-type Ca2 + current (ICaL) re-activation, and ICaL block was the most effective intervention to normalise repolarisation and diastolic Ca2 +, but compromised CaT amplitude. Late Na+ current (INaL) block partially abolished repolarisation abnormalities, with small impact on CaT. Na+/Ca2 + exchanger (INCX) block effectively restored repolarisation and CaT amplitude, but increased Ca2 + overload. Multichannel block increased efficacy in normalising repolarisation, AP biomarkers and CaT amplitude compared to selective block. Conclusions Experimentally-calibrated populations of human AP models identify ICaL re-activation as the key mechanism for repolarisation abnormalities in HCM, and combined INCX, INaL and ICaL block as effective anti-arrhythmic therapies also able to partially reverse the HCM electrophysiological phenotype.

[1]  Eric A. Sobie,et al.  Regression Analysis for Constraining Free Parameters in Electrophysiological Models of Cardiac Cells , 2009, PLoS Comput. Biol..

[2]  H. Watkins,et al.  Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. , 2011, Circulation research.

[3]  M. Shattock,et al.  Regulation of the cardiac Na(+) pump by palmitoylation of its catalytic and regulatory subunits. , 2013, Biochemical Society transactions.

[4]  A. Mugelli,et al.  Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment , 2013, Global cardiology science & practice.

[5]  Enno de Lange,et al.  Differential conditions for early after‐depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits , 2012, The Journal of physiology.

[6]  M. Yacoub,et al.  Response to letter regarding article, "Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy". , 2013, Circulation.

[7]  P. Elliott,et al.  Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[8]  A. McCulloch,et al.  Molecular and subcellular-scale modeling of nucleotide diffusion in the cardiac myofilament lattice. , 2013, Biophysical journal.

[9]  Carlos Sánchez,et al.  Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation , 2014, PloS one.

[10]  杜昕,et al.  Inherited cardiomyopathies , 2012 .

[11]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[12]  L. Rønn,et al.  In Vivo Effects of the IKr Agonist NS3623 on Cardiac Electrophysiology of the Guinea Pig , 2008, Journal of cardiovascular pharmacology.

[13]  J M de Bakker,et al.  Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. , 1994, Cardiovascular research.

[14]  A. McCulloch,et al.  A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII , 2014, The Journal of physiology.

[15]  A. Noma,et al.  A new integrated method for analyzing heart mechanics using a cell-hemodynamics-autonomic nerve control coupled model of the cardiovascular system. , 2008, Progress in biophysics and molecular biology.

[16]  A. Mebazaa,et al.  ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction , 2004, Current opinion in critical care.

[17]  L. McLain,et al.  Sudden death in young athletes. , 2003, Pediatric annals.

[18]  P. J. Griffiths,et al.  Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.

[19]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[20]  Eric A Sobie,et al.  Quantification of repolarization reserve to understand interpatient variability in the response to proarrhythmic drugs: a computational analysis. , 2011, Heart rhythm.

[21]  K. Sipido,et al.  Combined Na+/Ca2+ Exchanger and L-Type Calcium Channel Block as a Potential Strategy to Suppress Arrhythmias and Maintain Ventricular Function , 2013, Circulation. Arrhythmia and electrophysiology.

[22]  Yoram Rudy,et al.  Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation , 2011, PLoS Comput. Biol..

[23]  T. Hisada,et al.  Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator , 2015, Science Advances.

[24]  Alexander G. Fletcher,et al.  Chaste: A test-driven approach to software development for biological modelling , 2009, Comput. Phys. Commun..

[25]  C. Antzelevitch,et al.  Electrophysiologic Characteristics and Pharmacologic Response of Human Cardiomyocytes Isolated from a Patient with Hypertrophic Cardiomyopathy , 2013, Pacing and clinical electrophysiology : PACE.

[26]  S. Huke,et al.  Targets for therapy in sarcomeric cardiomyopathies. , 2015, Cardiovascular research.

[27]  R. Gilmour.  Early afterdepolarization-induced triggered activity: Initiation and reinitiation of reentrant arrhythmias. , 2004, Heart rhythm.

[28]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[29]  M. Yacoub,et al.  The Many Faces of Hypertrophic Cardiomyopathy: From Developmental Biology to Clinical Practice , 2009, Journal of cardiovascular translational research.

[30]  Trine Krogh-Madsen,et al.  Cell-Specific Cardiac Electrophysiology Models , 2015, PLoS Comput. Biol..

[31]  Lin Wu,et al.  A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Suppresses Experimental Arrhythmias , 2012, The Journal of Pharmacology and Experimental Therapeutics.

[32]  Carlos Sánchez,et al.  Na/K pump regulation of cardiac repolarization: insights from a systems biology approach , 2013, Pflügers Archiv - European Journal of Physiology.

[33]  W. Clusin,et al.  Calcium and Cardiac Arrhythmias: DADs, EADs, and Alternans , 2003, Critical reviews in clinical laboratory sciences.

[34]  J. Papp,et al.  Selective inhibition of sodium–calcium exchanger by SEA‐0400 decreases early and delayed afterdepolarization in canine heart , 2004, British journal of pharmacology.

[35]  D. Roden.  Repolarization reserve: a moving target. , 2008, Circulation.

[36]  Andrew D McCulloch,et al.  Nonequilibrium Reactivation of Na+ Current Drives Early Afterdepolarizations in Mouse Ventricle , 2014, Circulation. Arrhythmia and electrophysiology.

[37]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[38]  B. Rodríguez,et al.  Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology , 2013, Proceedings of the National Academy of Sciences.

[39]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[40]  A. Garfinkel,et al.  Early afterdepolarizations and cardiac arrhythmias. , 2010, Heart rhythm.

[41]  Y Rudy,et al.  Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. , 1995, Biophysical journal.

[42]  Kevin Burrage,et al.  Population of Computational Rabbit-Specific Ventricular Action Potential Models for Investigating Sources of Variability in Cellular Repolarisation , 2014, PloS one.

[43]  J. Papp,et al.  Selective Na+/Ca2+ exchanger inhibition prevents Ca2+ overload‐induced triggered arrhythmias , 2014, British journal of pharmacology.

[44]  R. Lazzara,et al.  Role of Calcium Loading in Early Afterdepolarizations Generated by Cs+ in Canine and Guinea Pig Purkinje Fibers , 1995, Journal of cardiovascular electrophysiology.

[45]  H. Watkins,et al.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. , 2003, Trends in genetics : TIG.

[46]  J. Levijoki,et al.  ORM‐10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart , 2013, British journal of pharmacology.

[47]  M. Maron,et al.  Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .

[48]  Richard J. Beckman,et al.  A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output From a Computer Code , 2000, Technometrics.

[49]  Z. Oko-Sarnowska,et al.  Sudden Cardiac Death in Hypertrophic Cardiomyopathy. , 2017, Cardiology in review.

[50]  H. Watkins,et al.  Inherited cardiomyopathies. , 2011, The New England journal of medicine.

[51]  Gary R. Mirams,et al.  mRNA Expression Levels in Failing Human Hearts Predict Cellular Electrophysiological Remodeling: A Population-Based Simulation Study , 2013, PloS one.

[52]  Craig T. January,et al.  Early Afterdepolarizations: Mechanism of Induction and Block A Role for L‐Type Ca2+ Current , 1989, Circulation research.

[53]  H. Wellens,et al.  Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. , 2000, Cardiovascular research.

[54]  Katja Rietdorf,et al.  Ca2+-sensitive fluorescent dyes and intracellular Ca2+ imaging. , 2013, Cold Spring Harbor protocols.

[55]  Yoram Rudy,et al.  Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient. , 2011, Journal of molecular and cellular cardiology.

[56]  L. Leatherbury,et al.  A novel mouse model of X-linked cardiac hypertrophy. , 2008, American journal of physiology. Heart and circulatory physiology.

[57]  C. Poggesi,et al.  Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy , 2013, Circulation.

[58]  Satoshi Matsuoka,et al.  Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte. , 2008, Progress in biophysics and molecular biology.

[59]  Amrita X. Sarkar,et al.  Exploiting mathematical models to illuminate electrophysiological variability between individuals , 2012, The Journal of physiology.

[60]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.